doi: 10.4088/PCC.11f01262.
Updates to diagnostic guidelines for Alzheimer's disease
Affiliations
- PMID: 22295259
- PMCID: PMC3267500
- DOI: 10.4088/PCC.11f01262
Item in Clipboard
Updates to diagnostic guidelines for Alzheimer's disease
Prim Care Companion CNS Disord.
2011.
No abstract available
Similar articles
-
Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." Addressing the challenge of Alzheimer's disease in the 21st century.Alzheimers Dement. 2011 May;7(3):335-7. doi: 10.1016/j.jalz.2011.04.002. Alzheimers Dement. 2011. PMID: 21575876 No abstract available.
-
Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.Alzheimers Dement. 2011 May;7(3):253-6. doi: 10.1016/j.jalz.2011.04.003. Alzheimers Dement. 2011. PMID: 21575869 No abstract available.
-
A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.Dementia (London). 2016 Mar;15(2):239-54. doi: 10.1177/1471301214525166. Epub 2014 Mar 24. Dementia (London). 2016. PMID: 24662500
-
Evaluation of DSM-5 and IWG-2 criteria for the diagnosis of Alzheimer's disease and dementia with Lewy bodies.Diagnosis (Berl). 2016 Mar 1;3(1):9-12. doi: 10.1515/dx-2015-0031. Diagnosis (Berl). 2016. PMID: 29540044 Review.
-
Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease.Curr Opin Pharmacol. 2018 Feb;38:1-7. doi: 10.1016/j.coph.2017.12.001. Epub 2017 Dec 23. Curr Opin Pharmacol. 2018. PMID: 29278824 Review.
Cited by
-
Ethical and social implications of using predictive modeling for Alzheimer's disease prevention: a systematic literature review protocol.BMJ Open. 2019 Mar 3;9(3):e026468. doi: 10.1136/bmjopen-2018-026468. BMJ Open. 2019. PMID: 30833325 Free PMC article.
-
Comprehensive Review on Alzheimer's Disease: Causes and Treatment.Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789. Molecules. 2020. PMID: 33302541 Free PMC article. Review.
-
Recent progresses in natural based therapeutic materials for Alzheimer's disease.Heliyon. 2024 Feb 15;10(4):e26351. doi: 10.1016/j.heliyon.2024.e26351. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38434059 Free PMC article. Review.
-
miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.J Alzheimers Dis. 2023;94(s1):S203-S225. doi: 10.3233/JAD-221298. J Alzheimers Dis. 2023. PMID: 37212107 Free PMC article. Review.
-
Photobiomodulation in Alzheimer's Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?Pharmaceutics. 2023 Mar 11;15(3):916. doi: 10.3390/pharmaceutics15030916. Pharmaceutics. 2023. PMID: 36986776 Free PMC article. Review.
References
-
- Sperling R.A., Aisen P.S., Beckett L.A., et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):280–292. - PMC - PubMed
-
- Albert M.S., DeKosky S.T., Dickson D., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270–279. - PMC - PubMed
-
- McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944. - PubMed
LinkOut - more resources
Full Text Sources
